Joy McCarthy

3.6k total citations
12 papers, 332 citations indexed

About

Joy McCarthy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Joy McCarthy has authored 12 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Otorhinolaryngology. Recurrent topics in Joy McCarthy's work include Economic and Financial Impacts of Cancer (2 papers), Cancer survivorship and care (2 papers) and Breast Cancer Treatment Studies (2 papers). Joy McCarthy is often cited by papers focused on Economic and Financial Impacts of Cancer (2 papers), Cancer survivorship and care (2 papers) and Breast Cancer Treatment Studies (2 papers). Joy McCarthy collaborates with scholars based in Canada, Australia and United States. Joy McCarthy's co-authors include Melanie Seal, Erin Powell, Renee Lester, Kara Laing, Erin R. Morgan, Deanna McLeod, George Dranitsaris, Christine Brezden‐Masley, Christine Simmons and Anil A. Joy and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Oral Oncology.

In The Last Decade

Joy McCarthy

9 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy McCarthy Canada 6 164 110 84 75 35 12 332
Neil Oronsky United States 12 137 0.8× 219 2.0× 97 1.2× 147 2.0× 28 0.8× 21 493
Nüket Eliyatkın Türkiye 6 102 0.6× 104 0.9× 94 1.1× 32 0.4× 29 0.8× 26 268
Hongying Zheng China 8 119 0.7× 111 1.0× 66 0.8× 102 1.4× 48 1.4× 23 310
Asiya Khan India 9 112 0.7× 125 1.1× 72 0.9× 54 0.7× 48 1.4× 18 288
Michael H. Wu United States 8 180 1.1× 224 2.0× 56 0.7× 101 1.3× 13 0.4× 8 390
Jaspreet Kaur India 10 77 0.5× 100 0.9× 54 0.6× 63 0.8× 19 0.5× 35 279
Takeshi Murata Japan 10 119 0.7× 94 0.9× 116 1.4× 44 0.6× 10 0.3× 26 296
Jingsi Dong China 12 184 1.1× 147 1.3× 153 1.8× 210 2.8× 30 0.9× 29 501

Countries citing papers authored by Joy McCarthy

Since Specialization
Citations

This map shows the geographic impact of Joy McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy McCarthy more than expected).

Fields of papers citing papers by Joy McCarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy McCarthy. The network helps show where Joy McCarthy may publish in the future.

Co-authorship network of co-authors of Joy McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Joy McCarthy. A scholar is included among the top collaborators of Joy McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy McCarthy. Joy McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Sehdev, Sandeep, Nigel S. B. Rawson, Marcus O. Butler, et al.. (2024). Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. 31(4). 1803–1816. 4 indexed citations
3.
Dzienis, Marcin, Juan Cundom, Anna Spreafico, et al.. (2024). Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC). International Journal of Radiation Oncology*Biology*Physics. 118(5). e3–e4. 1 indexed citations
4.
Simmons, Christine, Christine Brezden‐Masley, Joy McCarthy, Deanna McLeod, & Anil A. Joy. (2020). Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer. Therapeutic Advances in Medical Oncology. 12. 3863524131–3863524131. 16 indexed citations
5.
Lester, Renee, et al.. (2018). Advances in the Systemic Treatment of Triple-Negative Breast Cancer. Current Oncology. 25(11). 142–150. 232 indexed citations
6.
Morgan, Erin R., et al.. (2015). Using Tablet-Based Technology in Patient Education about Systemic Therapy Options for Early-Stage Breast Cancer: A Pilot Study. Current Oncology. 22(5). 364–369. 19 indexed citations
7.
McCarthy, Joy & Louise Porter. (2014). Prescription fraud: A comparison of pharmacists' and laypersons' perceptions of suspicious prescription presentation behaviour. International journal of law, crime and justice. 43(1). 50–67. 1 indexed citations
8.
Wood, Lori, et al.. (2014). Pharmacist-led monitoring program for patients on sunitinib for metastatic renal-cell carcinoma: A Canadian experience.. Journal of Clinical Oncology. 32(4_suppl). 479–479.
9.
Murphy, Laura, et al.. (2013). Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre. Supportive Care in Cancer. 21(6). 1557–1560. 3 indexed citations
10.
Noonan, Krista, et al.. (2012). A population-based analysis of patients with early-stage HER2-positive breast cancer in Newfoundland and Labrador. 6 indexed citations
11.
Edwards, Jonathan, et al.. (2011). Oral Anti-Cancer Agents in the Community Setting: A Survey of Pharmacists in Newfoundland and Labrador. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 144(5). 220–226. 13 indexed citations
12.
McCarthy, Joy. (2002). A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral Oncology. 38(7). 686–690. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Oronsky Breakdown of academic impact, for papers by Nüket Eliyatkın Breakdown of academic impact, for papers by Hongying Zheng Breakdown of academic impact, for papers by Asiya Khan Breakdown of academic impact, for papers by Michael H. Wu Breakdown of academic impact, for papers by Jaspreet Kaur Breakdown of academic impact, for papers by Takeshi Murata Breakdown of academic impact, for papers by Jingsi Dong
Rankless by CCL
2026